Monogram Orthopaedics, Inc. (MGRM) is a publicly traded company in the Healthcare sector, operating within the Medical - Devices industry. The company is headquartered in Austin, TX, United States. The current CEO is Benjamin Sexson.
MGRM has IPO date of 2023-05-18, 27 full-time employees, listed on the NASDAQ Capital Marke, a market capitalization of $243.79M.
Monogram Orthopaedics, Inc. focuses on developing a product solution architecture to enable mass personalized optimization of orthopedic implants. The company intends to produce and market robotic surgical equipment and related software, orthopedic implants, tissue ablation tools, navigation consumables, and other miscellaneous instrumentation for use in reconstructive joint replacement procedures. Its robot prototype executes optimized paths for high-precision insertion of optimized implants in synthetic bone specimens. The company was formerly known as Monogram Arthroplasty Inc. and changed its name to Monogram Orthopaedics, Inc. in March 2017. The company was incorporated in 2016 and is headquartered in Austin, Texas.
